Chemiluminiscence Imaging Market Size & Forecast Report, 2014 - 2025

Chemiluminescence Imaging or commonly known as CLIA is a doctrine predominantly witnessed in the healthcare sector and blotting techniques and their relevance in the detection of cancer has been well-documented. Chemiluminescence transpires or better still molecules of light are emitted when luminol, synthetic compound (C8H7N302) reacts with an oxidizing agent viz hydrogen peroxide. Chemiluminescence imaging marks its presence in forensic analysis by detecting traces of blood with iron content that emits a blue light under influence of an oxidizing agent or an oxidant.

Yet again, blue light emission states the presence of copper cyanide and specific proteins as they come in contact under influence of an oxidant in an observed chemical reaction. Secondary equipment coming in handy is an HD camera for imaging. Chemiluminescence also is used in biological assays to detect the presence of biomolecules and traces of inorganic ions. Luminescence accepts various sequences as biochemical for bioluminescence, photons for photoluminescence, and electromagnetic as electroluminescence based on excitation events.

Segmentation of chemiluminescence imaging market by applications include chemiluminescence immunoassays, hormones, insulin, thyroxin, estradiol, vitamin Vit 12, tumor markers, DNA hybridization detection, souther blotting, hybridization, western blotting, forensic science, food analysis, find organophosphorus most popular pesticide (Qunalphos).

Segmentation of the chemiluminescence market by region includes North America, Europe, Asia Pacific, MEA, and Latin America. North America is the foremost player in the field of chemiluminescence imaging followed by Europe. The chemiluminescence market is witnessing a high growth trajectory in North America and the Asia Pacific with an established presence of big players in the field of chemiluminescence imaging.

Chemiluminescence is a highly fragmented market with too many players in contention, both local and international. Product launches such as Odyssey launched by LI-COR Biosciences and with uncluttered use in segments across industries such as the biological and food analysis market drives growth in the chemiluminescence market. Drivers to the chemiluminescence market include its preferential use in food, medical and forensic industry and in pre-clinical tests and R& D by research institutes and pharmaceutical laboratories.

Product development has wide scope in research and development laboratories using chemiluminescence imaging enhancing growth in the chemiluminescence imaging market. As per industry news, chemiluminescence immunoassays offer the best solutions for the quantification of low concentrations of samples from an ambiguous mixture in comparison to RIA.

The non-radioactive nature of the technique is better still in applications ranging from microbiology, Agriculture, therapeutic and clinical segments. CLIA has a better playing field in developed economies such as North America and Europe being a fully automated version. Key industry players in the chemiluminescence imaging market include LI-COR Biosciences, Analytik Jena US, Azure Biosystems, Berthold Technologies GmbH & Co., KG, Syngene, GE Healthcare, Thermo Fischer Scientific, Analytic Jena Life Science, and PerkinElmer, Inc.